Human trials for a COVID-19 vaccine developed by Oxford University are starting in South Africa and in Brazil.
Some 2,000 people in South Africa will be involved in what is widely considered to be one of the earliest and most advanced trials for a vaccine to tackle the pandemic.
The first doses of the vaccine are being administered in Johannesburg this week.
South Africa has been chosen, not just for its expertise in this field, but because Covid-19 is now spreading fast here.
That makes it far easier for scientists to find a community at immediate risk of infection, and to then tell whether this British vaccine is effective.
Similar tests are already underway in the UK, but the infection rate there is slowing. Hence the move, not just to South Africa, but to Brazil too, where 5,000 people will be involved in the vaccine trial.
---BBC
Burkina Faso expels French diplomats for 'subversive activities'
GOIL reduces petrol price by 29 pesewas, sells GHC14.70 per litre
The disrespect towards security is terrible; we can do better — Atik Mohammed co...
Starlink to cease connection in Ghana, other “unavailable” countries on April 30...
MMCEs, DCEs and Regional Ministers must be elected to reduce political interfere...
National Cathedral: ‘Nonsense; you take taxes from broke Ghanaians to dig a clum...
April 18: Cedi sells at GHS13.59 to $1, GHS13.01 on BoG interbank
We must harness the collective power and ingenuity of female leaders to propel o...
Saglemi Housing Project will not be left to rot – Kojo Oppong Nkrumah
Asantehene commends Matthew Opoku Prempeh for conceiving GENSER Kumasi Pipeline ...
